RN-1101

N/A

Report date: 2025/12/09 15:52:43
NME

Base Information

Drug NameRN-1101
Drug Alias NameRN-1101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-TMEM180
TargetsTransmembrane Protein 180
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRin Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesRin Institute Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A